PDF Cover

Nasal Cannula Market

The market for Nasal Cannula was estimated at $8.3 billion in 2025; it is anticipated to increase to $12.0 billion by 2030, with projections indicating growth to around $17.5 billion by 2035.

Report ID:DS1801032
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Nasal Cannula
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Nasal Cannula Market Outlook

Revenue, 2025

$8.3B

Forecast, 2035

$17.5B

CAGR, 2026 - 2035

7.8%

The Nasal Cannula industry revenue is expected to be around $8.3 billion in 2026 and expected to showcase growth with 7.8% CAGR between 2026 and 2035. The need for nasal cannulas continues to grow in the respiratory care sector where rising hospital admissions due to chronic respiratory conditions and a demographic trend of an ageing population are prevalent. In addition, demand is on the increase for devices capable of supplying oxygen therapy across a range of care environments. Oxygen supply systems are used extensively in 72.7% of medical care given to patients, in the emergency room, in an intensive care ward and in out patient clinics. In the year 2025, the Nasal Cannula low flow product generated sales of approximately $5.24 billion. This reflects the popularity of cost effective devices that are also easy to use among medical professionals when dealing with stable and subacute patients. the focus on patient comfort and hygiene, coupled with the easy integration of the Nasal Cannula with leading ventilators and oxygen concentrators, has made it a vital tool in both acute and chronic respiratory care.

A nasal cannula is a medical tool which is adaptable, lightweight and flexible and has two prongs that are soft which sit in the patients nostrils. It has a hose that can be adjusted in length and can be used in conjunction with a wide variety of oxygen therapy machines. The device can deliver oxygen at varying rates. Hospitals, home healthcare settings and ambulatory care settings can use nasal cannula products because they offer better patient comfort, reduced skin irritation and better humidification. The use of the device is widespread in various fields including the treatment of severe lack of oxygen, oxygen therapy for patients with chronic lung disease and other breathing disorders, pre and post operation care, help for newborns and children with breathing problems and as a transitional step from ventilation treatment. The trend for the demand in this market is mainly driven by the increasing use of high flow nasal cannula therapy within hospitals intensive care units, and the preference for the production of cannulas which are used once, in order to reduce the risk of infection. Manufacturers are also designing their cannulas to fit the comfort of specific groups of patients. The use of portable oxygen therapy equipment is also becoming more popular, enabling patients to move around while being monitored remotely.

Nasal Cannula market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035
Nasal Cannula Market Outlook

Market Key Insights

  • The Nasal Cannula market is projected to grow from $8.3 billion in 2025 to $17.5 billion in 2035. This represents a CAGR of 7.8%, reflecting rising demand across Emergency Oxygen Therapy, Chronic Obstructive Pulmonary Disease Treatment, and Home Healthcare Solutions.

  • This market is dominated by a number of key companies, with Allied Medical, Teleflex Incorporated and Flexicare Medical among them. These companies are responsible for its current competitive landscape.

  • The US and Germany are this year leading the Nasal Cannula market. The U.S. and German markets are predicted to maintain a CAGR of 5.1% to 7.5% from 2025 through 2030.

  • Markets of Brazil, India and South Africa are expected to display the highest growth rate, which can be as much as 9 to 10.8%.

  • By 2030, the Nasal Cannula industry will be boosted by $999 million due to the shift towards the high flow nasal cannula.

  • The nasal cannula market is expected to grow by $9.3 billion over the period 2025 2030. This growth will be driven by demand from ambulatory healthcare services and long term care facilities.

  • The nasal cannula market is expected to rise 112% over the period 2025 to 2035. This growth can be attributed to a rise in breathing disorders. Advances in technology of the nasal cannula have also played a significant role in this rise.

nasal cannula market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Nasal Cannula - Country Share Analysis

Opportunities in the Nasal Cannula

Systems for healthcare in the U.S., Japan and Western Europe that are digital have opened up a new region for the development of intelligent Nasal Cannulae which are connected to sensors. The device offers real time data tracking on key factors including flow, adherence, saturation and leakage, this information can be transmitted via remote monitoring. This information is also useful for those with chronic respiratory conditions as well as those needing paediatric respiratory support. As the worlds respiratory therapy market grows, Nasal Cannulas can be improved through the incorporation of built in sensors which give treatment data.

Growth Opportunities in North America and Asia-Pacific

Nasal cannulas are most often used in North American hospitals, mainly in intensive care units and emergency departments. This is due to complex oxygen therapy techniques as well as acute respiratory care. Significant opportunities exist in the market for premium, clinically differentiated nasal cannulas that cater to users who require non invasive ventilation interfaces, integration with monitoring equipment and infection control focused nasal cannula lines that are used in post operative care and for patients suffering from chronic obstructive pulmonary disease. To achieve success in the market, manufacturers of respiratory care devices must focus on clinical outcomes. They must also use contracts which multiple businesses share and provide respiratory care devices bundled with oxygen therapy. Additionally, partnerships with medical institutions are required where the business educates the medical staff. The expansion of home health care and ambulatory care programmes is a further driver of growth. The growth is also driven by the positioning of comfort optimised and low flow oxygen equipment as a part of a continuity of care pathway back to the hospital respiratory care programme.
Across the Asia Pacific region, clinics offering out patient care and day surgery facilities appear to be gaining strategic importance for nasal cannula. This shift in focus is due to overcrowding at hospitals which is diverting both routine oxygen therapy and less serious respiratory conditions. Items for consideration include low cost, robust Nasal Cannula designs which allow for a high number of patients to be treated. They are designed so that the same equipment can be used in various oxygen flow situations and in different clinical environments. In the respiratory care devices market, the main players are a mix of both big global companies and smaller, rapidly expanding local firms. As a result, these businesses must differentiate themselves with regards to the quality of their products, their ability to comply with regulations and the training required to fit out their products. The region is experiencing urbanisation, an increase in respiratory diseases and growth in home healthcare and primary care facilities. This region needs respiratory care products such as nasal cannula to deal with patients who have COPD or other respiratory issues in community and nursing care homes. These range from a basic oxygen nasal cannula to a full non invasive ventilation system.

Market Dynamics and Supply Chain

01

Driver: Growing Prevalence of Respiratory Diseases and Expansion of Home Oxygen Therapy Services

The nasal cannula market is also strongly driven by the rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease, asthma, pneumonia, and sleep-disordered breathing, paired with the expansion of home oxygen therapy services. Globally, an aging population and environmental factors contribute to increased cases of COPD and other chronic respiratory conditions, raising demand for long-term oxygen delivery solutions. Nasal cannulas, particularly low-flow, extended-length, and conserver models, are also essential for delivering supplemental oxygen efficiently and comfortably to these patients. At the same time, healthcare systems worldwide are also shifting care from institutional settings to home environments, driven by cost-containment strategies and patient preferences for community-based care. This trend has also expanded the use of portable oxygen concentrators and home oxygen therapy services, making compatible nasal cannulas indispensable. Increased adoption of telehealth and remote monitoring platforms also supports home respiratory care, enabling clinicians to adjust oxygen delivery regimens based on patient data. Together, the surge in respiratory disease burden and the growth of home oxygen therapy are also elevating nasal cannula demand across clinical and home healthcare sectors.
A key driver in the nasal cannula market is also continuous technological innovation in cannula design and materials. Modern nasal cannulas feature softer prongs, lightweight tubing, and optimized airflow dynamics to enhance patient comfort during prolonged use. Advancements such as conserver cannulas reduce oxygen waste by delivering flow only on inhalation, increasing efficiency and reducing costs. Ergonomic and pediatric-specific designs also expand usability across diverse patient groups, driving broader adoption in both hospital and home care settings.
02

Restraint: Intense Price Competition and Low Product Differentiation Limit Profit Margins

The nasal cannula market faces intense price competition and minimal differentiation between basic product offerings, which restrains revenue growth. Many cannulas are commoditized, leading hospitals and home healthcare providers to make purchasing decisions primarily on cost rather than advanced features. This drives down average selling prices and profit margins for manufacturers, especially in price‑sensitive regions, and can slow investment in innovation as suppliers focus on competing through discounts rather than value‑added features.
03

Opportunity: Low flow Nasal Cannula adoption in ambulatory surgical centers and rehabilitation facilities across Europe and High flow Nasal Cannula for home oxygen therapy among elderly patients in China and India

Across Europe, the trend is for healthcare providers to move their surgery to day case units. This is creating a strong demand for low flow nasal cannulas in critical care units, recovery units and step down rehabilitation. The delivery of oxygen outside a hospital setting must ensure patient comfort and oxygen supply so as to lower the number of patients who need readmission. This oxygen supply must also allow for faster change of patients and standardised respiratory care processes. The low flow sector worldwide is predicted to grow from $5.24 billion in the year 2025 to $7.46 billion by the year 2030 at a 7.3% Compound Annual Growth Rate. Europe is expected to outperform this rate in the field of outpatient services.
Rapid urbanisation, an increase in the incidence of chronic obstructive pulmonary disease, and a lack of hospital beds are driving the demand for high flow nasal cannula in the domestic Asian market. By 2030 the global high flow revenues will have risen from $3.03 billion in 2025 to $4.58 billion, growing at a compound annual growth rate of 8.64%.In China and India, despite the presence of home oxygen therapy, older, low income individuals tend to prefer low maintenance oxygen therapy. Quick expansion of the adoption of high flow nasal cannula can be facilitated by partnerships between pharmacies and the local manufacture of medical products, and also by bundling home healthcare products.
04

Challenge: Supply Chain Vulnerabilities and Raw Material Shortages Disrupt Production Stability

Supply chain disruptions and raw material shortages, particularly for medical‑grade plastics and silicone, present ongoing challenges for nasal cannula manufacturers. Delays or cost spikes in materials directly affect production capacity and delivery times, leading to inventory shortages in hospitals and home care providers. These disruptions can reduce market availability during peak demand periods, erode customer trust, and force buyers to switch to alternate suppliers, impacting overall market dynamics and growth sustainability.

Supply Chain Landscape

1

Medical Tubing Inputs

BASF SEDow Inc.Covestro AG
2

Nasal Cannula Manufacturing

Allied Medical LLCTeleflex IncorporatedFlexicare Medical Ltd
3

Respiratory Care Distribution

ResMedVapothermTeleflex Incorporated
4

Oxygen Therapy End Users

HospitalsHomecare SettingsEmergency Medical Services
Nasal Cannula - Supply Chain

Use Cases of Nasal Cannula in Emergency Oxygen Therapy & Chronic Obstructive Pulmonary Disease Treatment

Emergency Oxygen Therapy : In emergency oxygen therapy, standard and high-flow nasal cannulas are widely used to deliver supplemental oxygen quickly and effectively to patients with acute respiratory distress, trauma, or cardiac events. Standard cannulas are common in ambulances and emergency departments due to their ease of use and rapid deployment, while high-flow systems provide higher oxygen concentrations for critical cases. Top suppliers like Vyaire Medical, Teleflex, Smiths Medical, and Cardinal Health lead with reliable, compliant connectors and tubing that ensure consistent oxygen delivery. Their products are valued for durability, broad compatibility with oxygen sources, and rapid availability in emergency settings, supporting life-saving interventions and acute care responsiveness.
Chronic Obstructive Pulmonary Disease Treatment : For COPD treatment, low-flow nasal cannulas and conserver cannulas that reduce oxygen waste are preferred for stable, long-term oxygen therapy. These devices offer patient comfort with soft, flexible prongs and lightweight materials suitable for extended wear. Manufacturers like Drive DeVilbiss Healthcare, Intersurgical, and Allied Healthcare Products provide cannulas designed to enhance mobility and compliance among COPD patients. Their strengths include comfort-focused designs that improve adherence to therapy and broad availability through respiratory care providers and clinics, supporting effective symptom management and better quality of life.
Home Healthcare Solutions : In the home healthcare segment, extended-length and pediatric nasal cannulas are commonly prescribed to support oxygen therapy outside clinical settings. These cannulas are designed for mobility, ergonomics, and compatibility with portable oxygen concentrators and home systems. Leading brands such as Philips Respironics, Invacare, Drive DeVilbiss Healthcare, and Fisher & Paykel Healthcare offer robust home-use cannulas with secure fittings and durable materials. Their products help caregivers provide reliable oxygen support for chronic conditions, postoperative recovery, and palliative care, reinforcing their strong positions in the home healthcare market through comfort, reliability, and service network strength.

Recent Developments

Recent developments in the nasal cannula market highlight a shift toward comfort‑enhanced designs, conserver cannulas, and integration with portable oxygen concentrators to support home oxygen therapy and chronic respiratory care. Manufacturers are focusing on lightweight materials, improved prong ergonomics, and efficient oxygen delivery systems that boost patient compliance and reduce waste. A key trend is the rise of telehealth‑linked respiratory monitoring, enabling clinicians to adjust oxygen flow remotely for COPD and post‑acute patients, expanding use in outpatient and home healthcare settings.

April 2025 : Fisher & Paykel Healthcare Ltd obtained FDA 510(k) clearance for its Optiflow+ nasal cannula line (small, medium, and large sizes) designed for high‑flow respiratory support, expanding its product offering for acute care settings.
May 2024 : Teleflex Incorporated completed the acquisition of Salter Labs, strengthening its neonatal and pediatric respiratory care portfolio, including advanced nasal cannula systems.
July 2023 : Flexicare Medical Ltd acquired Clement Clarke International (CCI), expanding its respiratory device portfolio, which includes nasal cannula products, and leveraging CCI’s heritage in respiratory care equipment.

Impact of Industry Transitions on the Nasal Cannula Market

As a core segment of the Medical Device industry, the Nasal Cannula market develops in line with broader industry shifts. Over recent years, transitions such as Shift Towards High-Flow Nasal Cannula and Technological Advancements and Innovation have redefined priorities across the Medical Device sector, influencing how the Nasal Cannula market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Shift Towards High-Flow Nasal Cannula

The nasal cannula market is undergoing a significant shift towards the use of high flow nasal cannula systems. This has led to the device evolving from an oxygen therapy accessory into a vital element in the respiratory care of patients. The high flow nasal cannula provides a more humidified oxygen therapy that has fewer complications than standard oxygen therapy equipment and it is also more comfortable for patients. This has resulted in a quicker adoption of this therapy in intensive care units for both newborns and adults. While improving outcomes through non invasive ventilation, HFNC also opens up significant revenue streams; by 2030 the increased use of HFNC is expected to boost the nasal cannula market by $999 million. As hospitals develop standardized protocols for high end respiratory machinery used in their facilities, nasal tube devices are predicted to become integral components of advanced respiratory care and oxygen therapy solutions for hospitals. This should lead to long term expansion in demand.
02

Technological Advancements and Innovation

Significant developments in the technology and design of nasal cannulas are greatly impacting the respiratory care industry. With improved ergonomics, devices which allow for adjustable flow rates and offer greater patient comfort are boosting their popularity in clinics, home care and critical care facilities. These innovations enhance the delivery of oxygen therapy through improving therapy effectiveness and patient compliance. Furthermore, they allow healthcare providers to provide oxygen therapy that is efficient, personalised and reliable. This positions modern nasal cannulas as essential tools in patient care and respiratory care management.